These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14995968)

  • 1. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.
    Gardner SY; Davis JL; Jones SL; LaFevers DH; Hoskins MS; McArver EM; Papich MG
    J Vet Pharmacol Ther; 2004 Feb; 27(1):57-60. PubMed ID: 14995968
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.
    Abd El-Aty AM; Goudah A; Shah SS; Shin HC; Shimoda M; Shim JH
    J Vet Pharmacol Ther; 2007 Dec; 30(6):586-91. PubMed ID: 17991229
    [No Abstract]   [Full Text] [Related]  

  • 3. Moxifloxacin penetration in bronchial secretions of mechanically ventilated patients with pneumonia.
    Leone M; Albanèse J; Sampol-Manos E; Simon N; Lacarelle B; Bruguerolle B; Martin C
    Antimicrob Agents Chemother; 2004 Feb; 48(2):638-40. PubMed ID: 14742226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinus tissue concentration of moxifloxacin after a single oral dose.
    Dinis PB; Monteiro MC; Martins ML; Silva N; Morais JG
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):142-6. PubMed ID: 14994771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies.
    Florian JA; Tornøe CW; Brundage R; Parekh A; Garnett CE
    J Clin Pharmacol; 2011 Aug; 51(8):1152-62. PubMed ID: 21228407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
    Wacke R; Förster S; Adam U; Mundkowski RG; Klar E; Hopt UT; Drewelow B
    J Antimicrob Chemother; 2006 Nov; 58(5):994-9. PubMed ID: 16956903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.
    Kees MG; Weber S; Kees F; Horbach T
    J Antimicrob Chemother; 2011 Oct; 66(10):2330-5. PubMed ID: 21729931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.
    Goudah A; Hasabelnaby S
    Res Vet Sci; 2010 Jun; 88(3):507-11. PubMed ID: 20004428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.
    Clode AB; Davis JL; Salmon J; LaFevers H; Gilger BC
    Am J Vet Res; 2010 May; 71(5):564-9. PubMed ID: 20433383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis.
    Skalioti C; Tsaganos T; Stamatiadis D; Giamarellos-Bourboulis EJ; Boletis J; Kanellakopoulou K
    Perit Dial Int; 2009; 29(5):575-9. PubMed ID: 19776053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
    Kim DH; Stark WJ; O'Brien TP
    Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations.
    Goudah A; Hasabelnaby S
    Chemotherapy; 2010; 56(1):26-31. PubMed ID: 20197659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.
    Metallidis S; Charokopos N; Nikolaidis J; Alexiadou E; Lazaraki G; Koumentaki E; Tsona A; Theodoridis G; Nikolaidis P
    Int J Antimicrob Agents; 2006 Nov; 28(5):428-32. PubMed ID: 17034992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
    Rink AD; Stass H; Delesen H; Kubitza D; Vestweber KH
    Clin Drug Investig; 2008; 28(2):71-9. PubMed ID: 18211115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin penetration into human gastrointestinal tissues.
    Wirtz M; Kleeff J; Swoboda S; Halaceli I; Geiss HK; Hoppe-Tichy T; Büchler MW; Friess H
    J Antimicrob Chemother; 2004 May; 53(5):875-7. PubMed ID: 15056642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.
    Cárceles CM; Villamayor L; Escudero E; Marín P; Fernández-Varón E
    Vet J; 2007 Mar; 173(2):452-5. PubMed ID: 16377219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
    Burkhardt O; Stass H; Thuss U; Borner K; Welte T
    Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration and accumulation of moxifloxacin in uterine tissue.
    Stass H; Kubitza D; Aydeniz B; Wallwiener D; Halabi A; Gleiter C
    Int J Gynaecol Obstet; 2008 Aug; 102(2):132-6. PubMed ID: 18501909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
    Lindstrom R; Lane S; Cottingham A; Smith S; Sall K; Silverstein S; Shettle L; Walters T; Faulkner R; Cockrum P; Teuscher N
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.